HERON THERAPEUTICS, INC. /DE/ - 10-Q Filing
Heron Therapeutics reports Q3 financial results including asset purchase agreement with CorMedix Inc.
Tickers: $HRTX
Read the full article at SEC EDGAR
Part of the story TROOPS, Inc. Enters Term Sheet with Young Platform to Develop Digital Asset Exchange (4 articles)